Free Trial
LON:FAB

Fusion Antibodies (FAB) Share Price, News & Analysis

Fusion Antibodies logo
GBX 6.89 +0.34 (+5.21%)
(As of 12/20/2024 11:56 AM ET)

About Fusion Antibodies Stock (LON:FAB)

Key Stats

Today's Range
6.62
7.20
50-Day Range
3.92
7.10
52-Week Range
2.80
8.50
Volume
1.60 million shs
Average Volume
1.18 million shs
Market Capitalization
£6.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. The company was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

Receive FAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter.

FAB Stock News Headlines

Fusion Antibody Share Chat (FAB)
How to piss off your liberal friends… and profit from it
Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.
See More Headlines

FAB Stock Analysis - Frequently Asked Questions

Fusion Antibodies' stock was trading at GBX 4.25 at the start of the year. Since then, FAB shares have increased by 62.1% and is now trading at GBX 6.89.
View the best growth stocks for 2024 here
.

Shares of FAB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fusion Antibodies investors own include 4D pharma (DDDD), Omega Diagnostics Group (ODX), Tullow Oil (TLW), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP) and Coats Group (COA).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

Net Income
£-2,190,000.00
Net Margins
-195.95%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.14 million
Cash Flow
GBX 0.76 per share
Book Value
GBX 2 per share

Miscellaneous

Free Float
N/A
Market Cap
£6.57 million
Optionable
Not Optionable
Beta
0.49
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (LON:FAB) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners